Disclosure: TotalCare Medical may be paid when readers use some partner links. This guide does not recommend a product. It does not link to a store.
By TotalCareMedical.com Health Team | August 2026
In This Article
The disclosed-versus-missing decision table
| What is shown | What is not shown | Why it matters | Exact next question |
|---|---|---|---|
| PT-141 | Amount | A name alone is not a dose plan. | What amount is on my prescription label? |
| L-citrulline | Amount | Long-term supplement safety has not been adequately assessed in the cited source. | What amount and source should I use to review it? |
| Tadalafil | Amount | The tadalafil label has a nitrate warning. | Does my medication list include anything affected by that warning? |
| Sildenafil | Amount | The sildenafil label lists nitrates and nitrites as contraindicated. | Does that label warning apply to my current medicines? |
The captured page calls QUAD a liquid under the tongue and a prescription. It also asks users of compounded medicine to discuss risks with a provider. Visit the current MEDVI page for the seller's current description.
What these label facts do—and do not—tell you
The warnings below come from separate ingredient labels. They do not tell us if MEDVI QUAD is safe, right for you, or likely to work.
The cited Vyleesi label covers subcutaneous bremelanotide in premenopausal women. It does not establish MEDVI QUAD route, dose, safety, indication, or effects in men.
That label is not a MEDVI label. It is not an answer for men.
- The tadalafil label says nitrates are contraindicated within 48 hours after the last dose.
- The sildenafil label says nitrates and nitrites are contraindicated.
- The Vyleesi label says it is not indicated for men and lists uncontrolled high blood pressure and known heart disease as contraindications.
- FDA says compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness, or quality before marketing.
Keep the product page and label facts apart. They answer different questions. Both can matter.
Two short conversations to have
With the prescriber: Ask for the amount of each ingredient. Ask how to use your prescription under the tongue. Review every warning against your medicine list.
With the pharmacy: Ask for the current complete label, the compounding pharmacy name, and the right contact for product-specific instructions.
Write down who answered. Write the date. Save the full label.
Primary sources used for this guide
- Current MEDVI page
- FDA: compounded-drug risks
- DailyMed: tadalafil label
- DailyMed: sildenafil label
- DailyMed: Vyleesi label
- Citrulline safety source
Related reading
Use the formula and safety comparison after you have the missing label facts. The DirectMax safety checklist shows a separate medication-overlap review path.
Bottom line: For MEDVI QUAD, the missing amounts are the blocker. Get the current full pharmacy label first. Then compare only the facts that belong to your prescription.
FDA boundary: This page is general information, not a diagnosis, prescription, dose plan, or substitute for a licensed clinician or pharmacist.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any supplement, medication, or treatment program. Individual results may vary.
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.